AVNS
Avanos Medical Inc
NYSE: AVNS · HEALTHCARE · MEDICAL DEVICES
$24.64
-0.06% today
Updated 2026-04-30
Market cap
$1.15B
P/E ratio
—
P/S ratio
1.64x
EPS (TTM)
$-1.57
Dividend yield
—
52W range
$9 – $25
Volume
1.4M
Avanos Medical Inc (AVNS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$24.64
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$64.45
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.7B | $0.7B | $0.7B | $0.7B | $0.7B | $0.7B | $0.7B | $0.7B | $0.7B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: -0.38% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -10.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.